Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 76.58%315.9M | 79.38%134M | 135.83%100.7M | 15.98%603.1M | 18.41%306.8M | -15.89%178.9M | 140.97%74.7M | 16.35%42.7M | 70.88%520M | 23.62%259.1M |
| Net income from continuing operations | 45.35%150M | 62.74%135.4M | 29.83%100.1M | 14.22%361.5M | 39.01%98M | 1.88%103.2M | -5.45%83.2M | 18.80%77.1M | 28.14%316.5M | -4.08%70.5M |
| Depreciation and amortization | 4.90%90M | -1.60%79.7M | 0.26%78.5M | 12.34%318.6M | 6.37%73.5M | 21.70%85.8M | 13.60%81M | 7.70%78.3M | 0.04%283.6M | -5.60%69.1M |
| Asset impairment expenditure | -105.84%-800K | -104.85%-800K | ---- | 11,533.33%34.9M | --4.3M | --13.7M | --16.5M | ---- | --300K | ---- |
| Remuneration paid in stock | 101.89%21.4M | -59.46%10.5M | 42.95%21.3M | 135.74%65.3M | 320.63%13.9M | 2.91%10.6M | 94.74%25.9M | 43.27%14.9M | -41.44%27.7M | -162.38%-6.3M |
| Remuneration paid in stock | 80.43%8.3M | 24.73%11.6M | -25.93%12M | -28.45%43M | -35.18%12.9M | -63.49%4.6M | -22.50%9.3M | 3.85%16.2M | 131.15%60.1M | 155.13%19.9M |
| Deferred tax | 72.66%44.2M | 23.21%-4.3M | ---- | 15.87%-42.4M | -235.52%-61.4M | 282.86%25.6M | 37.08%-5.6M | ---- | -16.67%-50.4M | -11.59%-18.3M |
| Other non cashItems | -76.47%-6M | -55.17%1.3M | 116.05%1.3M | 70.91%-1.6M | 43.24%5.3M | -151.52%-3.4M | 143.28%2.9M | 47.40%-8.1M | -139.13%-5.5M | 136.27%3.7M |
| Change In working capital | 114.38%8.8M | 28.23%-99.4M | 17.10%-112.5M | -56.90%-176.2M | 33.36%160.3M | -340.94%-61.2M | -0.36%-138.5M | -21.70%-135.7M | 55.79%-112.3M | 61.56%120.2M |
| -Change in receivables | 12.48%-129.7M | 66.13%-35.5M | 290.80%64.3M | -39.47%-167.5M | -15.11%120.2M | -92.72%-148.2M | 36.14%-104.8M | -62.80%-33.7M | 64.59%-120.1M | 471.65%141.6M |
| -Change in prepaid assets | 29.37%16.3M | -51.38%5.3M | -14.38%-18.3M | 170.83%3.4M | -32.26%-4.1M | 20.00%12.6M | 220.59%10.9M | -2.56%-16M | -71.43%-4.8M | -93.75%-3.1M |
| -Change in payables and accrued expense | 122.30%131.6M | -260.11%-67.7M | -62.39%-142.9M | 0.00%-59.6M | 78.21%-11.9M | 3.86%59.2M | -508.70%-18.8M | -51.20%-88M | -361.40%-59.6M | -188.06%-54.6M |
| -Change in other working capital | -161.84%-9.4M | 94.19%-1.5M | -880.00%-15.6M | -34.21%47.5M | 54.55%56.1M | -56.32%15.2M | -242.54%-25.8M | 111.76%2M | 10.74%72.2M | -30.33%36.3M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 76.58%315.9M | 79.38%134M | 135.83%100.7M | 15.98%603.1M | 18.41%306.8M | -15.89%178.9M | 140.97%74.7M | 16.35%42.7M | 70.88%520M | 23.62%259.1M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,217.43%-430.8M | 63.93%-59.3M | 94.71%-21.6M | -199.95%-605M | 100.75%200K | 29.68%-32.7M | -57.47%-164.4M | -1,600.42%-408.1M | -173.31%-201.7M | -53.14%-26.8M |
| Net PPE purchase and sale | 59.26%-14.3M | 52.85%-19M | 21.46%-16.1M | 1.59%-99M | 84.73%-3.1M | 12.03%-35.1M | -116.67%-40.3M | 5.96%-20.5M | -34.31%-100.6M | 29.02%-20.3M |
| Net business purchase and sale | ---417.1M | 70.25%-36.8M | --0 | -634.13%-555M | --0 | --0 | -63.62%-123.7M | ---431.3M | -50.00%-75.6M | --0 |
| Net investment purchase and sale | -50.00%200K | -54.17%-3.7M | -116.63%-6.9M | 189.89%33.8M | 55.81%-5.7M | 107.27%400K | 77.98%-2.4M | 600.00%41.5M | -197.92%-37.6M | -448.65%-12.9M |
| Net other investing changes | -80.00%400K | -90.00%200K | -36.36%1.4M | 25.62%15.2M | 40.63%9M | 281.82%2M | 185.71%2M | -63.93%2.2M | -7.63%12.1M | -37.25%6.4M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,217.43%-430.8M | 63.93%-59.3M | 94.71%-21.6M | -199.95%-605M | 100.75%200K | 29.68%-32.7M | -57.47%-164.4M | -1,600.42%-408.1M | -173.31%-201.7M | -53.14%-26.8M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 220.19%123.8M | -66.99%34.5M | -125.82%-53.8M | -39.16%-152.1M | -624.00%-362M | 54.04%-103M | -39.77%104.5M | 839.01%208.4M | 63.16%-109.3M | 71.83%-50M |
| Net issuance payments of debt | 289.00%149.5M | -53.12%60.2M | -112.96%-29.9M | 80.73%-58.1M | -10.42%-338.1M | 60.94%-79.1M | -36.72%128.4M | 1,617.76%230.7M | -76.11%-301.5M | -91.85%-306.2M |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 525.42%277.8M | ---- |
| Cash dividends paid | -7.53%-25.7M | -7.53%-25.7M | -7.17%-23.9M | -10.72%-94M | -10.65%-23.9M | -10.65%-23.9M | -10.14%-23.9M | -11.50%-22.3M | -8.57%-84.9M | -8.00%-21.6M |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---700K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 220.19%123.8M | -66.99%34.5M | -125.82%-53.8M | -39.16%-152.1M | -624.00%-362M | 54.04%-103M | -39.77%104.5M | 839.01%208.4M | 63.16%-109.3M | 71.83%-50M |
| Net cash flow | ||||||||||
| Beginning cash position | 57.88%344.5M | 27.32%254M | -35.25%228.5M | 137.96%352.9M | 52.62%262.5M | -4.21%218.2M | 51.25%199.5M | 137.96%352.9M | -20.57%148.3M | 24.01%172M |
| Current changes in cash | -79.40%8.9M | 637.84%109.2M | 116.11%25.3M | -173.68%-154M | -130.17%-55M | 174.61%43.2M | -85.21%14.8M | -912.90%-157M | 415.71%209M | 1,148.63%182.3M |
| Effect of exchange rate changes | 636.36%8.1M | -579.49%-18.7M | -94.44%200K | 772.73%29.6M | 1,600.00%21M | -47.62%1.1M | 192.86%3.9M | 500.00%3.6M | -115.83%-4.4M | 72.00%-1.4M |
| End cash Position | 37.71%361.5M | 57.88%344.5M | 27.32%254M | -35.25%228.5M | -35.25%228.5M | 52.62%262.5M | -4.21%218.2M | 51.25%199.5M | 137.96%352.9M | 137.96%352.9M |
| Free cash from | 109.74%301.6M | 234.30%115M | 281.08%84.6M | 20.20%504.1M | 27.18%303.7M | -16.78%143.8M | 177.42%34.4M | 48.99%22.2M | 82.82%419.4M | 31.93%238.8M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.